SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,593.24 -1,045.46
( -1.44%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,441.54 -16.96
(-0.16%)

Forex

USD-INR

96.37 0.10
(0.10%)

EUR-INR

108.33 0.45
(0.42%)

GBP-INR

127.68 0.44
(0.34%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

132.06

420483.45

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.91

Back

kobo biotech ltd

Aditya Birla Capital consolidated net profit rises 40.07% in the June 2026 quarter

Jul 31,2026

Net profit of Aditya Birla Capital rose 40.07% to Rs 1174.70 crore in the quarter ended June 2026 as against Rs 838.63 crore during the previous quarter ended June 2025. Sales rose 28.17% to Rs 12179.54 crore in the quarter ended June 2026 as against Rs 9502.69 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	12179.54	9502.69	28
OPM %	40.71	40.52	-
PBDT	1722.40	1253.23	37
PBT	1640.87	1181.94	39
NP	1174.70	838.63	40

71,593.24 -1,045.46 ( -1.44%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,343.08 -692.63 (-0.99%)

10,441.54 -16.96 (-0.16%)

96.37 0.10 (0.10%)

108.33 0.45 (0.42%)

127.68 0.44 (0.34%)

0.61 0.00 (0.01%)